2. Productos naturales
  3. Plants
  4. Araliaceae
  5. Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow

Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow

Panax notoginseng (Burkill) F. H. Chen ex C. H. Chow (25):

Cat. No. Nombre del producto No. CAS Pureza Estructura química
  • HY-N0615
    Notoginsenoside R1 80418-24-2 99.93%
    Notoginsenoside R1 (Sanchinoside R1), a saponin, is isolated from P. notoginseng. Notoginsenoside R1 exhibits anti-oxidation, anti-inflammatory, anti-angiogenic, and anti-apoptosis activities. Notoginsenoside R1 provides cardioprotection against ischemia/reperfusion (I/R) injury. Notoginsenoside R1 also provides neuroprotection in H2O2-induced oxidative damage in PC12 cells.
    Notoginsenoside R1
  • HY-N1477
    Dencichine 5302-45-4 99.59%
    Dencichin is a non-protein amino acid originally extracted from Panax notoginseng, and can inhibit HIF-prolyl hydroxylase-2 (PHD-2) activity.
    Dencichine
  • HY-N0910
    Notoginsenoside Ft1 155683-00-4 99.49%
    Notoginsenoside Ft1 is an orally active bioactive saponin. Notoginsenoside Ft1 inhibits the PI3K/AKT/mTOR signaling pathway, activates the p38 MAPK and ERK1/2 signaling pathways, and increases the proportion of CD8+ T cells, thereby inducing apoptosis and lysosomal cell death in various cancer cells, and promoting angiogenesis. Notoginsenoside Ft1 causes vasodilation by activating glucocorticoid receptors (GR) and estrogen receptor beta (ERβ) in endothelial cells. Notoginsenoside Ft1 increases intracellular Ca2+ accumulation, reduces cAMP levels by activating a signaling network mediated through P2Y12 receptors, and promotes platelet aggregation, thereby exerting a procoagulant effect. Notoginsenoside Ft1 inhibits ferroptosis (ferroptosis) in renal tubular epithelial cells by activating the TGR5 receptor, thereby demonstrating a renal protective effect. Notoginsenoside Ft1 acts as a TGR5 agonist and an FXR antagonist to combat obesity and insulin resistance.
    Notoginsenoside Ft1
  • HY-N6924
    Zingibroside R1 80930-74-1 99.75%
    Zingibroside R1 is an orally active triterpene saponin with multiple biological activities including antioxidant, anti-inflammatory, antiviral, and metabolic regulatory properties. Zingibroside R1 reduces the expression of PIN family members, inhibits the expression of PLT1/PLT2, WOX5, SHR, and SCR, disrupts auxin transport and distribution, triggers plant ROS responses, and inhibits root growth. Zingibroside R1 extends the lifespan of Caenorhabditis elegans, enhances its heat stress resistance, and improves its motor ability. Hydrogel derivatives of Zingibroside R1 inhibit the proliferation of Candida albicans by binding to its β-1,3-glucan and exhibit antifungal activity. Zingibroside R1 inhibits GLUT1-mediated uptake and alleviates liver injury. Zingibroside R1 can be used in research related to neurodegenerative diseases, vulvovaginal candidiasis, acute liver injury, Ehrlich ascites tumor and HIV-1 infection.
    Zingibroside R1
  • HY-N0909
    Notoginsenoside R2 80418-25-3 99.80%
    Notoginsenoside R2 (20(S)-Notoginsenoside R2; Ginsenoside Ng-R2) is an orally active notoginsenoside. Notoginsenoside R2 activates P90RSK and Nrf2 via the MEK1/2-ERK1/2 pathway to inhibit 6-OHDA-induced apoptotic damage in nerve cells. Notoginsenoside R2 upregulates SOX8/β-catenin by reducing miR-27a, thereby suppressing Aβ25-35-induced neuronal apoptosis and inflammatory responses. Notoginsenoside R2 alleviates lipid accumulation and mitochondrial dysfunction in diabetic nephropathy by inhibiting c-Src. Notoginsenoside R2 alleviates hepatic fibrosis by inducing hepatic stellate cell senescence and inhibiting the inflammatory microenvironment via JAK/STAT3 suppression. Notoginsenoside R2 can be used in research related to Parkinson's disease, Alzheimer's disease, diabetic nephropathy and hepatic fibrosis.
    Notoginsenoside R2
  • HY-N18382
    5,6-Didehydroginsenoside Rb1 1268459-69-3
    5,6-Didehydroginsenoside Rb1 is a dammarane-type saponin. 5,6-Didehydroginsenoside Rb1 can be isolated from the dried roots of Panax notoginseng.
    5,6-Didehydroginsenoside Rb1
  • HY-N17972
    Floranotoginsenoside D 1179351-17-7
    Floranotoginsenoside D (Compound 4) is a dammarane-type triterpene saponin found in the flowers of Panax notoginseng.
    Floranotoginsenoside D
  • HY-128393
    Trilinolein 537-40-6 98.0%
    Trilinolein is an orally active triglyceride that inhibits the PI3K/Akt, Ras/MEK/ERK signaling pathways, and MMP-2. Trilinolein can reduce oxidative stress, induce apoptosis, and inhibit cell migration. Trilinolein can be used in the research fields of cardiovascular disease, cerebrovascular disease (such as cerebral ischemia), and non-small cell lung cancer.
    Trilinolein
  • HY-P1936
    Cyclo(Gly-L-Pro) 3705-27-9 99.86%
    Cyclo(Gly-L-Pro) is a Alkaloids product that can be isolated from the roots of Panax notoginseng (Burk.)F.H.Chen.
    Cyclo(Gly-L-Pro)
  • HY-N2531
    Notoginsenoside Fc 88122-52-5 ≥99.0%
    Notoginsenoside Fc, a protopanaxadiol- (PPD-) type saponin isolated from the leaves of Panax notoginseng, effectively counteracts platelet aggregation. Notoginsenoside Fc can accelerate reendothelialization following vascular injury in diabetic rats by promoting autophagy.
    Notoginsenoside Fc
  • HY-N0046
    Notoginsenoside Fe 88105-29-7 99.99%
    Notoginsenoside Fe (Notoginseng triterpenes; Ginsenoside Mb) is a saponin with anti-obesity and anti-neuroblastoma activities. Notoginsenoside Fe can be isolated from leaves of Panax notoginseng. Notoginsenoside Fe specifically activates paraventricular nucleus neurons in the hypothalamus, effectively reducing body weight, improving fasting blood glucose and protecting liver function by decreasing food intake, increasing resting metabolic rate and enhancing energy expenditure. Notoginsenoside Fe also inhibits the c-Src signaling pathway, blocks the proliferation and viability of human neuroblastoma cells, while improving mitochondrial dysfunction and alleviating apoptosis. Notoginsenoside Fe can be used in studies related to diet-induced obesity and neuroblastoma.
    Notoginsenoside Fe
  • HY-N10151
    Notoginsenoside R3 87741-76-2 98.15%
    Notoginsenoside R3 is an active principle components of P. notoginseng. Notoginsenoside R3 act as a signaling molecule that is associated with various physiological effects. P. notoginseng and its components are used as traditional Chinese medicine for cardiovascular disease.
    Notoginsenoside R3
  • HY-N2530
    Notoginsenoside Fa 88100-04-3 99.71%
    Notoginsenoside Fa, a protopanaxadiol (ppd)-type saponin isolated from P. notoginseng, could possibly activate and recover the function of degenerated brain.
    Notoginsenoside Fa
  • HY-N6581
    Notoginsenoside T5 769932-34-5
    Notoginsenoside T5 is a dammarane 61 glycoside. Notoginsenoside T5 is isolated from the acidic deglycosylation of saponins from the roots of P. 62 notoginseng.
    Notoginsenoside T5
  • HY-N4305
    Notoginsenoside FP2 1004988-75-3 99.61%
    Notoginsenoside FP2, a dammarane-Type Bisdesmoside isolated from the Fruit Pedicels of Panax notoginseng, has potential to treat cardiovascular disease.
    Notoginsenoside FP2
  • HY-N5019
    Notoginsenoside S 575446-95-6 98.84%
    Notoginsenoside S is a compound isolated from Panax notoginseng.
    Notoginsenoside S
  • HY-N11226
    Ginsenoside Ra0 112722-00-6
    Ginsenoside Ra0 (compound 17) is a dammarane-type saponin that can be isolated from Panax notoginseng.
    Ginsenoside Ra0
  • HY-N16751
    Notoginsenoside D 193895-50-0
    Notoginsenoside D is a dammarane-type triterpene oligoglycoside. Notoginsenoside D can be isolated from the dried roots of Panax notoginseng (BURK.) F. H. CHEN. Notoginsenoside D can be used in the research of liver injury.
    Notoginsenoside D
  • HY-N2530R
    Notoginsenoside Fa (Standard) 88100-04-3
    Notoginsenoside Fa (Standard) is the analytical standard of Notoginsenoside Fa. This product is intended for research and analytical applications. Notoginsenoside Fa, a protopanaxadiol (ppd)-type saponin isolated from P. notoginseng, could possibly activate and recover the function of degenerated brain.
    Notoginsenoside Fa (Standard)
  • HY-N0909R
    Notoginsenoside R2 (Standard) 80418-25-3
    Notoginsenoside R2 (Standard) is the analytical standard of Notoginsenoside R2. This product is intended for research and analytical applications.
    Notoginsenoside R2 (Standard)